SEC Filing Summary: Signal Genetics, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Signal Genetics, Inc. on November 13, 2015, reporting events as of November 12, 2015. The filing serves to disclose a business update and third-quarter 2015 financial results via a press release (Exhibit 99.1). Note: The request metadata referenced "Viridian Therapeutics, Inc.," but the filing text explicitly identifies the registrant as Signal Genetics, Inc.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text. Consequently, the filing text does not provide a clear value for any specific financial figure.
Material Changes
The filing indicates the company issued a press release highlighting "Recent Achievements" and reporting third-quarter 2015 financial results. Specific details regarding material changes compared to the prior period are not present in the 8-K text and are located in the attached press release.
Guidance, Outlook, and Risks
The filing includes a Regulation FD Disclosure (Item 7.01) regarding the business update. The text explicitly states that the information in this report and the attached press release shall not be deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed in the 8-K text itself.
Investor Verification Checklist
- Verify the specific third-quarter 2015 financial figures (revenue, net loss, cash position) in the attached Press Release (Exhibit 99.1).
- Confirm the nature of the "Recent Achievements" mentioned in the business update.
- Review the full text of the press release for any forward-looking statements or updated guidance not captured in this summary.
- Ensure the correct registrant name (Signal Genetics, Inc.) is used, as the metadata contained a discrepancy.